Loading…
Albumin as a prognostic marker for ulcerative colitis
AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i....
Saved in:
Published in: | World journal of gastroenterology : WJG 2017-12, Vol.23 (45), p.8008-8016 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143 |
---|---|
cites | cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143 |
container_end_page | 8016 |
container_issue | 45 |
container_start_page | 8008 |
container_title | World journal of gastroenterology : WJG |
container_volume | 23 |
creator | Khan, Nabeel Patel, Dhruvan Shah, Yash Trivedi, Chinmay Yang, Yu-Xiao |
description | AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,> 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis. |
doi_str_mv | 10.3748/wjg.v23.i45.8008 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5725295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849555253484856</cqvip_id><sourcerecordid>1979174816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMoWqt3T7JHL1vzuUkuQil-geBFzyGbpNvU7aYmuxX_vSmtRXOZwDzzzvAAcIXghHAqbr-WzWSDycRTNhEQiiMwwhjJEgsKj8EIQchLSTA_A-cpLSHEhDB8Cs6wxEwSXo0Am7b1sPJdoVOhi3UMTRdS702x0vHDxWIeYjG0xkXd-40rTGh979MFOJnrNrnLfR2D94f7t9lT-fL6-DybvpSGUtiX2hqsreCVQQhSYi01HHFLsBSM40ozSypbazOH0NWIVrgWNXKWZYoyjCgZg7td7nqoV84a1_VRt2odfT7vWwXt1f9O5xeqCRuV4xmWLAfc7ANi-Bxc6tXKJ-PaVncuDEkhySXKJlGVUbhDTQwpRTc_rEFQbW2rbFtl2yrbVlvbeeT673mHgV-9GSD7zEXomk_fNQdGQrF9kkEqqGSMYUbyT7CK_ABDQowC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1979174816</pqid></control><display><type>article</type><title>Albumin as a prognostic marker for ulcerative colitis</title><source>PubMed Central</source><creator>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</creator><creatorcontrib>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</creatorcontrib><description>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v23.i45.8008</identifier><identifier>PMID: 29259376</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Adult ; Aged ; Biomarkers - blood ; Colectomy ; Colitis, Ulcerative - blood ; Colitis, Ulcerative - diagnosis ; Colitis, Ulcerative - therapy ; Female ; Follow-Up Studies ; Humans ; Hypoalbuminemia - blood ; Immunosuppressive Agents - therapeutic use ; Male ; Middle Aged ; Prognosis ; Retrospective Cohort Study ; Retrospective Studies ; Risk Factors ; Serum Albumin - analysis ; Severity of Illness Index ; Time Factors ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; United States ; United States Department of Veterans Affairs - statistics & numerical data</subject><ispartof>World journal of gastroenterology : WJG, 2017-12, Vol.23 (45), p.8008-8016</ispartof><rights>The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</citedby><cites>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725295/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725295/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29259376$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Nabeel</creatorcontrib><creatorcontrib>Patel, Dhruvan</creatorcontrib><creatorcontrib>Shah, Yash</creatorcontrib><creatorcontrib>Trivedi, Chinmay</creatorcontrib><creatorcontrib>Yang, Yu-Xiao</creatorcontrib><title>Albumin as a prognostic marker for ulcerative colitis</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Colectomy</subject><subject>Colitis, Ulcerative - blood</subject><subject>Colitis, Ulcerative - diagnosis</subject><subject>Colitis, Ulcerative - therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypoalbuminemia - blood</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Retrospective Cohort Study</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Serum Albumin - analysis</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>United States</subject><subject>United States Department of Veterans Affairs - statistics & numerical data</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMoWqt3T7JHL1vzuUkuQil-geBFzyGbpNvU7aYmuxX_vSmtRXOZwDzzzvAAcIXghHAqbr-WzWSDycRTNhEQiiMwwhjJEgsKj8EIQchLSTA_A-cpLSHEhDB8Cs6wxEwSXo0Am7b1sPJdoVOhi3UMTRdS702x0vHDxWIeYjG0xkXd-40rTGh979MFOJnrNrnLfR2D94f7t9lT-fL6-DybvpSGUtiX2hqsreCVQQhSYi01HHFLsBSM40ozSypbazOH0NWIVrgWNXKWZYoyjCgZg7td7nqoV84a1_VRt2odfT7vWwXt1f9O5xeqCRuV4xmWLAfc7ANi-Bxc6tXKJ-PaVncuDEkhySXKJlGVUbhDTQwpRTc_rEFQbW2rbFtl2yrbVlvbeeT673mHgV-9GSD7zEXomk_fNQdGQrF9kkEqqGSMYUbyT7CK_ABDQowC</recordid><startdate>20171207</startdate><enddate>20171207</enddate><creator>Khan, Nabeel</creator><creator>Patel, Dhruvan</creator><creator>Shah, Yash</creator><creator>Trivedi, Chinmay</creator><creator>Yang, Yu-Xiao</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171207</creationdate><title>Albumin as a prognostic marker for ulcerative colitis</title><author>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Colectomy</topic><topic>Colitis, Ulcerative - blood</topic><topic>Colitis, Ulcerative - diagnosis</topic><topic>Colitis, Ulcerative - therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypoalbuminemia - blood</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Retrospective Cohort Study</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Serum Albumin - analysis</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>United States</topic><topic>United States Department of Veterans Affairs - statistics & numerical data</topic><toplevel>online_resources</toplevel><creatorcontrib>Khan, Nabeel</creatorcontrib><creatorcontrib>Patel, Dhruvan</creatorcontrib><creatorcontrib>Shah, Yash</creatorcontrib><creatorcontrib>Trivedi, Chinmay</creatorcontrib><creatorcontrib>Yang, Yu-Xiao</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Nabeel</au><au>Patel, Dhruvan</au><au>Shah, Yash</au><au>Trivedi, Chinmay</au><au>Yang, Yu-Xiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Albumin as a prognostic marker for ulcerative colitis</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2017-12-07</date><risdate>2017</risdate><volume>23</volume><issue>45</issue><spage>8008</spage><epage>8016</epage><pages>8008-8016</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>29259376</pmid><doi>10.3748/wjg.v23.i45.8008</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2017-12, Vol.23 (45), p.8008-8016 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5725295 |
source | PubMed Central |
subjects | Adrenal Cortex Hormones - therapeutic use Adult Aged Biomarkers - blood Colectomy Colitis, Ulcerative - blood Colitis, Ulcerative - diagnosis Colitis, Ulcerative - therapy Female Follow-Up Studies Humans Hypoalbuminemia - blood Immunosuppressive Agents - therapeutic use Male Middle Aged Prognosis Retrospective Cohort Study Retrospective Studies Risk Factors Serum Albumin - analysis Severity of Illness Index Time Factors Tumor Necrosis Factor-alpha - antagonists & inhibitors United States United States Department of Veterans Affairs - statistics & numerical data |
title | Albumin as a prognostic marker for ulcerative colitis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A09%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Albumin%20as%20a%20prognostic%20marker%20for%20ulcerative%20colitis&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Khan,%20Nabeel&rft.date=2017-12-07&rft.volume=23&rft.issue=45&rft.spage=8008&rft.epage=8016&rft.pages=8008-8016&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v23.i45.8008&rft_dat=%3Cproquest_pubme%3E1979174816%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1979174816&rft_id=info:pmid/29259376&rft_cqvip_id=90888889504849555253484856&rfr_iscdi=true |